Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Changes in the beta 2-microglobulin level during hemodialysis].

L P Nikitinskaia, E A Stetsiuk, I S Iarmolinskiĭ

    Urologiia I Nefrologiia
    |September 1, 1990
    PubMed
    Summary

    Beta 2-microglobulin levels remain high in hemodialysis patients. Hemodiafiltration with polysulfone membranes effectively removes beta 2-microglobulin, unlike standard hemodialysis methods.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Renal function after surgical treatment of stag-horned nephrolithiasis].

    Urologiia (Moscow, Russia : 1999)·2010
    Same author

    Protein dynamics control of electron transfer in photosynthetic reaction centers from Rps. sulfoviridis.

    The journal of physical chemistry. B·2008
    Same author

    Effects of ischemic and hypoxic preconditioning on the state of mitochondria and function of ischemic kidneys.

    Bulletin of experimental biology and medicine·2007
    Same author

    Experimental intravenous cell therapy of acute and chronic renal failure.

    Bulletin of experimental biology and medicine·2007
    Same author

    Functional aftereffects of intraparenchymatous injection of human fetal stem and progenitor cells to rats with chronic and acute renal failure.

    Bulletin of experimental biology and medicine·2006
    Same author

    [The role of phytotherapy in pre- and postoperative period in patients with urolithiasis].

    Urologiia (Moscow, Russia : 1999)·2005

    Area of Science:

    • Nephrology
    • Biochemistry

    Background:

    • Beta 2-microglobulin (β2M) is a protein marker often elevated in patients with chronic kidney disease undergoing dialysis.
    • Understanding β2M dynamics during renal replacement therapy is crucial for managing associated complications.

    Purpose of the Study:

    • To investigate the impact of different dialyzer membranes and dialysis modalities on beta 2-microglobulin levels.
    • To evaluate the efficacy of hemodialysis and hemodiafiltration in reducing beta 2-microglobulin.

    Main Methods:

    • Comparative analysis of beta 2-microglobulin levels in patients undergoing hemodialysis with cuprophane and polysulfone membranes.
    • Assessment of beta 2-microglobulin changes during hemodiafiltration using a polysulfone membrane dialyzer.
    • Measurement of pre- and post-dialysis beta 2-microglobulin concentrations.

    Main Results:

    • Patients exhibited significantly elevated beta 2-microglobulin levels (approx. 20x normal) irrespective of dialysis method.
    • Neither cuprophane nor polysulfone membranes in standard hemodialysis significantly altered beta 2-microglobulin levels.
    • Hemodiafiltration with a highly permeable polysulfone membrane demonstrated effective elimination of beta 2-microglobulin.

    Conclusions:

    • Standard hemodialysis, regardless of membrane type, does not effectively reduce elevated beta 2-microglobulin levels.
    • Hemodiafiltration represents a promising therapeutic strategy for the clearance of beta 2-microglobulin in dialysis patients.

    Related Experiment Videos